CA
NZ
UK
AU
IND
US
…
Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. The company has a strategic collaboration with Canlab International for the development, manufacturing, and commercialization of a portfolio of novel natural peptide candidates targeting weight management, anti-aging and longevity, tissue repair and regeneration, hair restoration, and hormonal optimization. Genvor Incorporated is based in Henderson, Nevada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown |
|---|
| Breakdown |
|---|
| Breakdown | 2022-09-30 | 2021-09-30 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2022-09-30 | 2021-09-30 |
| Net income | -5.98M | -3.44M |
| Capital expenditures | 0.00M | 0.00M |
Sector: Basic Materials Industry: Agricultural Inputs
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| GNVR GNVR |
- -% |
0.75 | - | - | - | - |
| CTA-PB E. I. du Pont de Nemours and Company |
-0.33 0.59% |
55.25 | - | - | 3.43 | - |
| CTVA Corteva Inc |
-0.06 0.46% |
11.87 | 49.93 | 19.65 | 3.12 | 2.19 |
| CTA-PA E. I. du Pont de Nemours and Company |
- -% |
46.00 | - | - | 2.71 | - |
| NTR Nutrien Ltd |
-0.88 1.25% |
69.32 | 15.94 | 14.90 | 1.38 | 1.42 |
Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. The company has a strategic collaboration with Canlab International for the development, manufacturing, and commercialization of a portfolio of novel natural peptide candidates targeting weight management, anti-aging and longevity, tissue repair and regeneration, hair restoration, and hormonal optimization. Genvor Incorporated is based in Henderson, Nevada.
1550 W Horizon Ridge Pkwy, Henderson, NV, United States, 89012
715 903 6473
5
| Name | Title | Year Born |
|---|---|---|
| Mr. Chad Pawlak Sr. | CEO, CFO & Director | 1973 |
| Dr. Jesse M. Jaynes Ph.D. | Chief Research Officer, Chief Scientific Officer & Director | 1951 |
| Dr. Windy Dean-Colomb M.D., Ph.D. | Chief Clinical Officer | NA |
| Dr. George Stavrides | Executive Vice President of Business Development & Commercialization | NA |
| Mr. Chad Pawlak Sr. | CEO & Director | 1973 |
| Mr. Donald A. Kalkofen B.A. | Chief Financial Officer | 1964 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.39%
Communication Services
+0.40%
Consumer Cyclical
-0.20%
Consumer Defensive
-0.56%
Energy
-0.45%
Financial Services
-0.09%
Financials
+0.11%
Healthcare
+0.40%
Industrials
+0.34%
Real Estate
-0.14%
Technology
+0.88%
Utilities
+0.11%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...